Druckenmiller's Viking Trade Just Hit A Golden Cross — And A Sweet 36% Gain

Stanley Druckenmiller's firm bought Viking Therapeutics stock (VKTX) during Q2 at $25.33. Now up 36%, VKTX shows a Golden Cross.

Spotlight on Viking Therapeutics: Analyzing the Surge in Options Activity

After a thorough review of the options trading surrounding Viking Therapeutics, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
Stocktwits on MSN

Viking Therapeutics Stock Powers Toward Best Month Of The Year — Wall Street, Retail Bulls Fired Up On Obesity Drug Promise

VKTX shares have surged about 45% in October, set for their strongest monthly gain of 2025. ・Traders on Stocktwits linked ...

Viking Therapeutics (VKTX): Assessing Valuation After Shares Jump 28% in the Past Month

Viking Therapeutics (VKTX) has captured investor attention with its recent stock movement, delivering a 28% gain over the past month. This comes as traders revisit the company’s ongoing expansion in ...